Mandate

Vinge’s Forensic, Risk & Compliance Group assists Tele2

Tele2 has decided to leave Kazakhstan and has today published the terms and conditions governing the transaction.

In connection with the exit, Tele2 has issued the extensive report "Tele2 Kazakhstan - Exit Report on Ethics and Compliance". The Exit Report is part of Tele2’s obligation to act ethically, to fight corruption and be transparent to shareholders and the market. 
 
Vinge’s Forensic, Risk & Compliance Group has assisted Tele2 in conjunction with the company’s analysis and reporting of the anti‑corruption work which Tele2 has conducted since it arrived in Kazakhstan. In the Exit Report, Tele2 describes its method of identifying and addressing corruption risks. This method is based on Vinge’s formulated best practice – a compliance programme consisting of 10 steps which companies and organizations should implement in order to prevent bribery and corruption in their business operations. 

“It is very satisfying to work with a company which takes the risks of corruption seriously. It is not possible to prevent everything, although you can establish a framework and procedures which minimize the risk significantly”,

says Mia Falk, Head of Forensic, Risk & Compliance at Vinge.

For more information, please see Tele2’s press release as well as Tele2 Kazakhstan - Exit Report on Ethics and Compliance

Vinge’s team consisted of Mia Falk and Hayaat Ibrahim.

Related

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026

Vinge has advised SBP Kredit AB (publ) in connection a securitisation with a Nordic bank as senior lender

The agreement covers a total amount of SEK 1 billion and creates conditions for significantly increased lending capacity. The agreement has been structured in accordance with the EU Securitisation Regulation and enables qualified loans to be continuously transferred to a special purpose vehicle within the SBP group.
September 14, 2026